Assessing endurance in Parkinson's patients using a pegboard test
Investigation of the Validity and Reliability of the 6-Minute Pegboard and Ring Test in Parkinson's Patients for Upper Extremity Endurance Assessments
This study is testing a new pegboard test to see if it can effectively measure upper body endurance in people with Parkinson's disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 34 (estimated) |
| Ages | 45 Years to 75 Years |
| Sex | All |
| Sponsor | Karadeniz Technical University Academic / other |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06482502 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the validity of the 6-Minute Pegboard and Ring Test (6-MPRT) as a measure of upper extremity endurance in patients with Parkinson's disease. The study will involve two assessments conducted on the same day by different evaluators, with a follow-up assessment occurring two days later. In addition to the 6-MPRT, other tests such as the Weight Lifting Test and the 30-Second Arm Curl Test will also be utilized to evaluate endurance. The goal is to determine if the 6-MPRT can be effectively used in this patient population, where current assessment methods are limited.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with Parkinson's disease who have a Hoehn & Yahr staging of 3 or less and meet specific upper extremity mobility criteria.
Not a fit: Patients with severe heart disease, orthopedic problems affecting the upper extremity, or secondary neurological diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a reliable method for assessing upper extremity endurance in Parkinson's patients, potentially improving rehabilitation strategies.
How similar studies have performed: Previous studies have validated the 6-MPRT in other respiratory disease groups, suggesting potential applicability in Parkinson's patients, though this specific application is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hoehn \& Yahr staging ≤3 points, * Individuals who have not undergone a rehabilitation program of at least 20 days in the last 6 months, * Those with full upper extremity shoulder flexion and abduction active joint range of motion. Exclusion Criteria: * Those with severe heart disease such as heart failure, cardiac arrhythmia, hypertension, * People with any orthopedic problem that will affect the upper extremity, * Having a secondary neurological disease diagnosis, * Having vision impairment that may affect measurement methods (not corrected by glasses), * Having a cognitive disease that may cause difficulty in following the researchers\' commands, * Those who had changes in their medical use during the test (dose increase/decrease, drug change
Where this trial is running
Istanbul
- İstanbul Medilife Beylikdüzü Hospital — Istanbul, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Emre Şenocak, PhD
- Email: emre.senocak@windowslive.com
- Phone: +90 553 569 56 92
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.